Therapeutic and persistent efficacy of spinosad applied as a pour-on or a topical spray against natural infestations of chewing and sucking lice on cattle.
Studies were conducted in Wisconsin and Illinois, USA, to assess and compare the therapeutic and persistent efficacy of spinosad when applied as either a pour-on or topical spray and compared with cyfluthrin pour-on and coumaphos topical spray for controlling natural infestations of chewing (Bovicola bovis) and sucking (Linognathus vituli, Solenopotes capillatus and Haematopinus eurysternus) lice on cattle. Thirty-five animals at each trial site were blocked according to pre-treatment lice counts and randomly allocated to one of five treatment groups: single treatments of spinosad (25 g/L), diluted with water to 0.04% active ingredient and applied as a whole-body topical spray; spinosad (25 g/L) applied as a neat pour-on at 2 mg/kg body weight; Co-Ral Emulsifiable Livestock Insecticide (5.8% coumaphos), diluted to 0.03% active ingredient and applied as a whole-body topical spray; CyLence Pour-on Insecticide (1% cyfluthrin), applied as a neat pour-on at the manufacturer's recommended use rate for lice; and untreated control. Both spinosad treatments and cyfluthrin provided > or =96% control of B. bovis for up to 7 weeks, whereas the efficacy of coumaphos dropped to <90% after week 5 at one site. Spinosad spray had the best therapeutic and residual control of all treatments against L. vituli, > or =98% for at least 5 weeks at both sites, compared with 3 weeks for coumaphos at one site. Spinosad and coumaphos sprays provided 100% control of S. capillatus for at least 8 weeks compared with > or =97% control for spinosad and cyfluthrin pour-on treatments over the same interval. While H. eurysternus burden was low and limited to one study site, all four treatments provided 100% control for at least 6 weeks. These studies showed that topically applied spinosad provided a high degree of therapeutic and residual control against both sucking and chewing lice.
White
W Hunter
WH
Elanco Animal Health Research and Development, Division of Eli Lilly & Company, Greenfield, IN, United States.
Hutchens
Douglas E
DE
Jones
Carl
C
Firkins
Larry D
LD
Paul
Allan J
AJ
Smith
Larry L
LL
Snyder
Daniel E
DE
D000287:Administration, Topical; D000818:Animals; D000854:Anoplura / Q000187:drug effects* / Q000254:growth & development; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy* / Q000517:prevention & control; D003372:Coumaphos / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D005260:Female; D007306:Insecticides / Q000627:therapeutic use*; D010373:Lice Infestations / Q000188:drug therapy / Q000517:prevention & control / Q000662:veterinary*; D018942:Macrolides / Q000627:therapeutic use*; D008297:Male; D009570:Nitriles / Q000627:therapeutic use; D008003:Phthiraptera / Q000187:drug effects* / Q000254:growth & development; D011722:Pyrethrins / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
D004338:Drug Combinations; D007306:Insecticides; D018942:Macrolides; D009570:Nitriles; D011722:Pyrethrins; D003372:Coumaphos; C052570:cyfluthrin; C415329:spinosad